Cerebrovascular disease is associated with dementia and functional disability in human observational studies, with sarcopenia in older inpatients and cognitive frailty in people with type 2 diabetes. It is also linked with higher mortality after osteoporotic hip fracture and with postoperative cognitive dysfunction after hip fracture surgery.
201 findings in 177 papers from 1987 to 2026, 34 of them since April 2026
“as did women with prior cerebrovascular disease (1.51, 1.32-1.73)”
Antihypertensive agents prevent cerebrovascular disease in humans (hypertensive) (NNT 43 (95% CI, 31 to 69)).
“43 subjects (95% confidence interval [CI], 31 to 69) and 61 subjects (95% CI, 39 to 141) needed to be treated for 5 years to prevent one cerebrovascular event”
Cerebrovascular disease is linked with worse cognitive function in humans (β 1.25 (95% CI 0.38-2.12), P=0.005).
“Micro[+]/Macro[+] phenotype (β, 1.25 [95% CI, 0.38-2.12]; P=0.005) were associated with worse cognitive abilities compared with HA-negative and Micro[-]/Macro[-] participants”
Humanscompared with Micro[-]/Macro[-] participants; adjusted for sociodemographics, clinical comorbidities, and cerebrovascular/neurodegenerative lesionsbrainn = 1,584
Cerebrovascular disease is linked with cognitive function in humans (non-demented) (17 to 24%).
“The association between SBPV and cognition was partially mediated by CeVD and brain atrophy, with mediation proportion ranging from 17 to 24% for CeVD”
Cerebrovascular disease is linked with cognitive function in humans.
“effects of ET on cognition seemed to be largely explainable by severity of concomitant CeVD, specifically white matter hyperintensities, and brain atrophy”
Cerebrovascular disease is linked with worse cognitive function in humans.
“the mixed CVD profile group (but not the single CVD profile group) showed a faster cognitive decline across all domains assessed compared with decedents without CVD neuropathology.”
Cerebrovascular disease impairs cognitive function in humans.
“large and/or small infarction, intracranial hemorrhage, subarachnoid hemorrhage, atherosclerosis, amylod angiopathy are also more directly associated with cognitive decline”
Cerebrovascular disease was not clearly linked with grip strength in humans.
“neurodegenerative pathologies including tau tangles, TDP-43, and nigral neuronal loss were associated with declining grip strength, but not CVD pathologies.”
Cerebrovascular disease is linked with cognitive decline in humans (depression) (z = -3.525, P < 0.001).
“cerebrovascular disease (z = -3.525, P < 0.001), HbA1C (z = -4.976, P < 0.001) and physical inactivity (z = -3.998, P < 0.001) partially mediated the association between depression and cognitive decline”
Canadian journal of psychiatry. Revue canadienne de psychiatrie·
Age-related hearing loss
↔no changein humans1
1 study
Cerebrovascular disease was not clearly linked with age-related hearing loss in humans.
“Nonspecific amyloid deposition, neurofibrillary tangle staging, overall AD neuropathology level, and cerebrovascular disease were not clearly associated with increased risks of hearing impairment.”
PPARG protects against cerebrovascular disease (central nervous system diseases).
“PPAR-γ shows significant neurovascular protective effect through multiple signaling axes such as NF-κB, Nrf2 and AMP-activated protein kinase (AMPK).”
Cerebrovascular disease is linked with a higher risk of mortality in humans (presence of cerebrovascular disease in type 2 diabetic foot patients) (2.463 times (p=0.002)).
“presence of cerebrovascular disease increased death by 2.463 times (p=0.002)”
Humanspresence of cerebrovascular disease in type 2 diabetic foot patients1-year
Cerebrovascular disease is linked with a higher risk of mortality in humans following osteoporotic hip fracture (HR=1.429; 95% CI, 1.232-1.657).
“The incidence and mortality of fractures increased when there were increasing age, more than three underlying diseases (HR=1.945; 95% CI, 1.284-2.945), cerebrovascular diseases (HR=1.429; 95% CI, 1.232-1.657), and renal diseases (HR=1.248; 95% CI, 1.040-1.497).”
Cerebrovascular disease predicts mortality in humans (older cancer survivors).
“Significant cardiometabolic predictors of mortality included in the final model are age, sex, history of cerebrovascular disease, non-adherence to exercise guidelines (150min moderate activity per week), and smoking.”
Cerebrovascular disease is linked with a higher risk of dementia in humans (compared with coronary artery disease) (HR 2.09 (95% CI 1.61-2.71)).
“Dementia risk was higher in participants with peripheral artery disease (HR 1.68; 95% CI 1.24-2.28) and cerebrovascular disease (HR 2.09; 95% CI 1.61-2.71) than in those with coronary artery disease.”
Humanscompared with coronary artery diseasemedian follow-up of 10.1 yearsn = 10,321
Cerebrovascular disease is linked with a higher risk of dementia in humans (adjusted for age).
“Once adjusted for age, cerebrovascular disease, chronic kidney disease, diabetes, low education and problems with mobility and incontinence were significantly associated with dementia.”
Tirzepatide is linked with a lower risk of cerebrovascular disease in humans (compared with semaglutide, patients with T2DM undergoing CABG) (11.8% vs. 17.5%; HR = 0.831; adjusted p = 0.0024).
“reduced incidence of cerebrovascular disease (11.8% vs. 17.5%; HR = 0.831)”
Humanscompared with semaglutide, patients with T2DM undergoing CABG
Cerebrovascular disease is associated with hypertension in humans (Compared with participants without stroke or TIA).
“Hypertension, smoking, higher WHR, lower alcohol consumption and diabetes were all more common in people with cerebrovascular disease (p<0.0001 for each).”
HumansCompared with participants without stroke or TIA
Cerebrovascular disease is associated with frailty in humans (early-onset frailty trajectory).
“Compared with the robust group, the early-onset group showed a higher prevalence of cerebrovascular diseases, bone and joint diseases, poor nutrition, sarcopenia, hospitalization, low cognitive function, and smoking”
Cerebrovascular disease is linked with a higher risk of frailty in people with HIV, adjusted for age, sex, and multimorbidity (HR 2.52, 95% CI 1.29 to 4.93).
“Cerebrovascular disease, diabetes, and COPD were independent predictors of transition to frailty within 30 months in models adjusted for age, sex, and multimorbidity”
Humansin people with HIV, adjusted for age, sex, and multimorbidity30 monthsn = 219
Journal of acquired immune deficiency syndromes (1999)·
Telomere length
↑upin humans2↔no changein humans1RR 1.14–1.42
2 studies
Telomere length is associated with cerebrovascular disease in humans.
“Results show that shorter telomere length is associated with various types of CVD, including stroke, ischemic stroke, hemorrhagic stroke, and cardioembolic stroke.”
Telomere length raises the risk of cerebrovascular disease in humans (shortest versus longest third of leucocyte telomere length) (RR 1.42, 95% CI 1.11 to 1.81).
“The pooled relative risk for cerebrovascular disease was 1.42 (1.11 to 1.81), with no significant heterogeneity between studies”
Reviewshortest versus longest third of leucocyte telomere length
Cerebrovascular disease raises the risk of clinical dementia In the presence of Alzheimer's disease pathology.
“Cerebrovascular disease, particularly cerebral small vessel disease also interacts with Alzheimer’s disease pathology to increase the chance that Alzheimer’s disease pathology will result in clinical dementia.”
ReviewIn the presence of Alzheimer's disease pathology
Cerebrovascular disease raises the risk of clinical dementia in humans with Alzheimer's disease pathology.
“cerebrovascular disease not only commonly co-occurs with Alzheimer's disease (AD) and increases the probability that AD pathology will result in clinical dementia”
Diabetic peripheral neuropathy is linked with a higher risk of cerebrovascular disease in humans (type 2 diabetes; neuropathy defined as VPT>25 V) (IRR 1.48 (CI 1.20-1.83) in T2D).
“For CBVD, the IRRs were 1.50 (CI 1.30-1.97) in T1D and 1.48 (CI 1.20-1.83) in T2D.”
Humanstype 2 diabetes; neuropathy defined as VPT>25 Vn = 9,395
Homelessness is associated with cerebrovascular disease in humans (men residing in shelters) (8.9%).
“Sequelae of cerebrovascular disease (ICD-10: I69) affected 8.9% of participants; this subgroup was older and had higher rates of disability certification and hospitalization”
Homelessness is linked with a lower risk of cerebrovascular disease in humans (veterans without prior cerebrovascular disease) (HR 0.30, 95% CI 0.29-0.32).
“Overall, the earliest homelessness episode and earliest subsequent cerebrovascular disease event were negatively associated (hazard ratios (HR) = 0.30 [95% confidence intervals (CI): 0.29, 0.32])”
Humansveterans without prior cerebrovascular disease2017 to 2021
Nutrition, metabolism, and cardiovascular diseases : NMCD·
Cerebrovascular disease is associated with alcohol in humans (Compared with participants without stroke or TIA).
“Hypertension, smoking, higher WHR, lower alcohol consumption and diabetes were all more common in people with cerebrovascular disease (p<0.0001 for each).”
HumansCompared with participants without stroke or TIA
Human studies link cerebrovascular disease to dementia, cognitive impairment and an early-onset frailty trajectory. They also associate it with functional disability in community-dwelling adults, sarcopenia in older inpatients and falls in women, and report higher mortality after osteoporotic hip fracture.
In human cohorts, higher red cell distribution width links to increased risk of cerebrovascular disease in metabolic dysfunction-associated steatotic liver disease, and specific polygenic scores predict risk in women with prior hypertensive disorders of pregnancy. Cerebrovascular disease also increases mortality in individuals with gastric carcinoma in situ.
In 234 people assessed for brain artery disease, advanced MRI detected more than twice the tissue volume found by a validated conventional MRI-based method.In 234 people assessed for brain artery disease, advanced MRI detected more than twice the tissue volume found by a validated conventional MRI-based method.
Compared with no vaccination, estimated effectiveness against virus-related respiratory hospitalization was 100% with neurological or cerebrovascular disease (zero versus…Compared with no vaccination, estimated effectiveness against virus-related respiratory hospitalization was 100% with neurological or cerebrovascular disease (zero versus one event) and 82.4% without.
What changedVaccine effectiveness against RSV-related respiratory hospitalization was similar: 100% with neurological/cerebrovascular disease versus 82.4% without
The catchOnly one RSV-related respiratory hospitalization occurred among participants with neurological or cerebrovascular disease